about
Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patientsEradication therapy for Burkholderia cepacia complex in people with cystic fibrosisEradication therapy for Burkholderia cepacia complex in people with cystic fibrosisPulmonary fibrosis: pathogenesis, etiology and regulationReliability of quantitative real-time PCR for bacterial detection in cystic fibrosis airway specimensTrue microbiota involved in chronic lung infection of cystic fibrosis patients found by culturing and 16S rRNA gene analysis.The microorganisms in chronically infected end-stage and non-end-stage cystic fibrosis patients.Clinical profile, diagnostic delay, and genetic make-up of cystic fibrosis in Kashmir, India.Assessment of airway microbiota and inflammation in cystic fibrosis using multiple sampling methodsA novel zinc binding system, ZevAB, is critical for survival of nontypeable Haemophilus influenzae in a murine lung infection model.Tracking humoral responses using self assembling protein microarraysThroat Swabs and Sputum Culture as Predictors of P. aeruginosa or S. aureus Lung Colonization in Adult Cystic Fibrosis PatientsQuorum-sensing blockade as a strategy for enhancing host defences against bacterial pathogens.Animal models of chronic lung infection with Pseudomonas aeruginosa: useful tools for cystic fibrosis studies.Outer membrane protein P5 is required for resistance of nontypeable Haemophilus influenzae to both the classical and alternative complement pathwaysEradication therapy for Burkholderia cepacia complex in people with cystic fibrosis.Acute intratracheal Pseudomonas aeruginosa infection in cystic fibrosis mice is age-independent.Clinical Outcomes Associated with Achromobacter Species Infection in Patients with Cystic Fibrosis.Genome-wide study of Pseudomonas aeruginosa outer membrane protein immunogenicity using self-assembling protein microarrays.TESTS TO ASSESS SENSITIZATION TO ASPERGILLUS FUMIGATUS IN CYSTIC FIBROSIS.Geographical differences in first acquisition of Pseudomonas aeruginosa in cystic fibrosis.Antimicrobial susceptibility and molecular typing of MRSA in cystic fibrosis.Comparative genome characterization of Achromobacter members reveals potential genetic determinants facilitating the adaptation to a pathogenic lifestyle.High relatedness selects against hypermutability in bacterial metapopulations.Cystic fibrosis: the conductance regulator, ceramides, and possible treatments.
P2860
Q21562196-CDFCCF71-021D-4A4F-BB64-1921B32A7B82Q24193082-FDE440E7-0E2E-4523-9B0E-A212548C7471Q24198175-32238FE1-65E3-4B5A-8AD4-8C95DD0CF666Q28388425-18CAB7EE-EDBB-4BCD-9829-A76C8719E349Q33770039-804F04D4-15CC-47C6-BD5E-43773CFF02EFQ34051927-E19CA47D-BD1C-4800-A498-A3E215E31C5EQ34115440-A7B9EFB9-B8EA-41E2-B713-C5420DEF6BDEQ35030301-747E740C-59B0-4059-9727-CC39598E6064Q35127881-9A32CBD7-868F-4B19-8E81-53C3502F10E9Q35139325-2BD15449-199E-4A6A-8F69-32026C3B737DQ35170395-7B3F9EF5-0546-40E4-A9F6-F70C6F5EF519Q36155055-99FE5BAC-B021-4F83-BC6F-0BF5C48C52E3Q36732549-296D7CA9-CEF1-42FE-82EA-795705D67D3EQ37265316-4377277E-703C-4450-9337-95B7D2F79F68Q37546512-8544600D-C9FA-451F-A2B1-6A6F4D2DD1B2Q38996423-2FE1B20C-4A98-4646-A922-58A1689E0A84Q40075329-7FC72FC2-61F2-40A5-BA52-669D6E3699C3Q40252432-C63A1E1E-D3B7-4C08-868B-B6B12C163B69Q41763271-E3D6F1A5-59CF-4481-BED1-8E98AFEF68D4Q43379142-13F386FD-74F2-4894-B85B-F8B0A7864F01Q45029608-10EA1EF9-933D-48A1-8440-768D4B903C46Q50908688-A09A20FB-0601-4B4B-9837-B2FDD56F589BQ50923935-DE2B3FD1-D15E-47E7-A97A-B9538A143D88Q51711564-85CDA5B0-AB07-49AB-9291-BFD1F9C18B41Q52836080-CCF3B3CA-FA3D-4FF2-8E1B-92FA1699FD12
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականին հրատարակուած գիտական յօդուած
@hyw
2004 թվականին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Microbiology of early CF lung disease
@ast
Microbiology of early CF lung disease
@en
Microbiology of early CF lung disease
@nl
type
label
Microbiology of early CF lung disease
@ast
Microbiology of early CF lung disease
@en
Microbiology of early CF lung disease
@nl
prefLabel
Microbiology of early CF lung disease
@ast
Microbiology of early CF lung disease
@en
Microbiology of early CF lung disease
@nl
P3181
P1476
Microbiology of early CF lung disease
@en
P2093
Lisa Saiman
P304
P3181
P356
10.1016/S1526-0542(04)90065-6
P407
P478
P577
2004-01-01T00:00:00Z